HomeCompareADBCF vs MRK

ADBCF vs MRK: Dividend Comparison 2026

ADBCF yields 97.56% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $15.2K in total portfolio value· pulled ahead in Year 9
10 years
ADBCF
ADBCF
● Live price
97.56%
Share price
$2.05
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.6K
Annual income
$20.14
Full ADBCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ADBCF vs MRK

📍 MRK pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADBCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADBCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADBCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADBCF
Annual income on $10K today (after 15% tax)
$8,292.68/yr
After 10yr DRIP, annual income (after tax)
$17.12/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,311.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADBCF + MRK for your $10,000?

ADBCF: 50%MRK: 50%
100% MRK50/50100% ADBCF
Portfolio after 10yr
$49.2K
Annual income
$4,909.14/yr
Blended yield
9.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ADBCF
No analyst data
Altman Z
3.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADBCF buys
0
MRK buys
0
No recent congressional trades found for ADBCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADBCFMRK
Forward yield97.56%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$41.6K$56.8K
Annual income after 10y$20.14$9,798.13
Total dividends collected$13.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ADBCF vs MRK ($10,000, DRIP)

YearADBCF PortfolioADBCF Income/yrMRK PortfolioMRK Income/yrGap
1$15,578$4,878.05$11,206$366.19+$4.4KADBCF
2$20,219$3,550.96$12,650$502.35+$7.6KADBCF
3$23,789$2,153.72$14,407$694.19+$9.4KADBCF
4$26,638$1,184.06$16,585$967.82+$10.1KADBCF
5$29,122$619.57$19,342$1,363.89+$9.8KADBCF
6$31,477$316.52$22,913$1,947.19+$8.6KADBCF
7$33,840$159.87$27,662$2,823.89+$6.2KADBCF
8$36,289$80.31$34,159$4,173.35+$2.1KADBCF
9← crossover$38,870$40.25$43,337$6,308.80$4.5KMRK
10$41,611$20.14$56,776$9,798.13$15.2KMRK

ADBCF vs MRK: Complete Analysis 2026

ADBCFStock

Adbri Limited manufactures, imports, distributes, and markets construction materials in Australia. The company operates in two segments: Cement, Lime, Concrete and Aggregates; and Masonry. It provides cement, lime, premixed concrete, aggregates, and sand; various concrete bricks, besser blocks, pavers, and retaining wall blocks; and industrial minerals comprising agricultural lime products, stockfield minerals and fillers for glass manufacturing, and quick and hydrated lime for industrial processing and water treatment applications. The company offers its products to residential and non-residential construction, engineering construction, industrial manufacturing, and mining markets. The company was formerly known as Adelaide Brighton Limited and changed its name to Adbri Limited in May 2020. Adbri Limited was founded in 1882 and is based in Sydney, Australia.

Full ADBCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ADBCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADBCF vs SCHDADBCF vs JEPIADBCF vs OADBCF vs KOADBCF vs MAINADBCF vs JNJADBCF vs ABBVADBCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.